These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37844997)

  • 1. Effects of Deslorelin on Testosterone Secretion and Testicular Volume in Male Rhesus Macaques (
    Tran HD; Carroll KE; Mackiewicz AL; Ardeshir A; Stockinger D; De Lucena T; Christe KL
    J Am Assoc Lab Anim Sci; 2023 Nov; 62(6):525-530. PubMed ID: 37844997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal Suppression in Female Rhesus Macaques (
    Carroll KE; Mackiewicz AL; Ardeshir A; Alber SA; Christe KL
    J Am Assoc Lab Anim Sci; 2022 May; 61(3):226-233. PubMed ID: 35512995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in testicular steroidogenic acute regulatory (STAR) protein, steroidogenic enzymes and testicular morphology associated with increased testosterone secretion in bulls receiving the luteinizing hormone releasing hormone agonist deslorelin.
    Aspden WJ; Rodgers RJ; Stocco DM; Scott PT; Wreford NG; Trigg TE; Walsh J; D'Occhio MJ
    Domest Anim Endocrinol; 1998 Jul; 15(4):227-38. PubMed ID: 9673455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continued desensitization of the pituitary gland in young bulls after treatment with the luteinizing hormone-releasing hormone agonist deslorelin.
    Bergfeld EG; D'Occhio MJ; Kinder JE
    Biol Reprod; 1996 Apr; 54(4):769-75. PubMed ID: 8924495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable duration of reproductive suppression in male coyotes (Canis latrans) treated with a high dose of the gonadotrophin-releasing hormone agonist deslorelin.
    MacGregor MJ; Asa CS; Skinner DC
    Reprod Fertil Dev; 2017 Jul; 29(7):1271-1279. PubMed ID: 27161891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reestablishment of sperm quality after long-term deslorelin suppression in tomcats.
    Nuñez Favre R; García MF; García Mitacek MC; Rearte R; Fontaine C; de la Sota RL; Stornelli MA
    Anim Reprod Sci; 2018 Aug; 195():302-308. PubMed ID: 29934121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Length of efficacy and effect of implant location in adult tom cats treated with a 9.4 mg deslorelin subcutaneous implant.
    Romagnoli S; Baldan A; Ferro S; Righetti C; Scenna L; Gabai G; Badon T; Fontaine C; Mollo A; Stelletta C; Milani C
    J Feline Med Surg; 2019 Jun; 21(6):507-519. PubMed ID: 30056772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of luteinizing hormone (LH) and testosterone secretion, pituitary responses to LH-releasing hormone (LHRH), and reproductive function in young bulls receiving the LHRH agonist deslorelin: effect of castration on LH responses to LHRH.
    D'Occhio MJ; Aspden WJ
    Biol Reprod; 1996 Jan; 54(1):45-52. PubMed ID: 8837999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term release GnRH agonist "deslorelin" on testicular HSP expression, accessory sex glands and testicular functions in adult male rats.
    Eşki F; Çetin N; Uslu S; Uslu BA; Şendağ S; Yörük M; Naseer Z; Wehrend A; Shakeel M
    Theriogenology; 2019 Aug; 134():104-111. PubMed ID: 31158733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible suppression of sexual activity in tomcats with deslorelin implant.
    Novotny R; Cizek P; Vitasek R; Bartoskova A; Prinosilova P; Janosovska M
    Theriogenology; 2012 Sep; 78(4):848-57. PubMed ID: 22578617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of implants containing the GnRH agonist deslorelin on testosterone release and semen characteristics in Shetland stallions.
    Gautier C; Schmidt K; Aurich J; Aurich C
    Anim Reprod Sci; 2018 Aug; 195():230-241. PubMed ID: 29859702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproductive seasonality and the effect of the GnRH agonist deslorelin as a contraceptive in captive male Black Flying-foxes (Pteropus alecto).
    Melville DF; O'Brien GM; Crichton EG; Theilemann P; McKinnon A; Johnston SD
    Theriogenology; 2012 Feb; 77(3):652-61. PubMed ID: 22115809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predominant suppression of follicle-stimulating hormone β-immunoreactivity after long-term treatment of intact and castrate adult male rats with the gonadotrophin-releasing hormone agonist deslorelin.
    Smith AW; Asa CS; Edwards BS; Murdoch WJ; Skinner DC
    J Neuroendocrinol; 2012 May; 24(5):737-47. PubMed ID: 22172059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response studies for pituitary and testicular function in male dogs treated with the GnRH superagonist, deslorelin.
    Junaidi A; Williamson PE; Martin GB; Blackberry MA; Cummins JM; Trigg TE
    Reprod Domest Anim; 2009 Oct; 44(5):725-34. PubMed ID: 19769638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary and testicular endocrine responses to exogenous gonadotrophin-releasing hormone (GnRH) and luteinising hormone in male dogs treated with GnRH agonist implants.
    Junaidi A; Williamson PE; Martin GB; Stanton PG; Blackberry MA; Cummins JM; Trigg TE
    Reprod Fertil Dev; 2007; 19(8):891-8. PubMed ID: 18076821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of a 4.7 mg deslorelin slow release implant in male dogs in the field.
    Vasetska A; Körber H; Pilgram C; Schuler G; Aslan S; Saral G; Binli F; Akal E; Selcuk M; Ay S; Findik M; Fontaine CS; Goericke-Pesch S
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2023 Aug; 51(4):231-241. PubMed ID: 37820614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GnRH-agonist implantation of prepubertal male cats affects their reproductive performance and testicular LH receptor and FSH receptor expression.
    Mehl NS; Khalid M; Srisuwatanasagul S; Swangchan-Uthai T; Sirivaidyapong S
    Theriogenology; 2016 Mar; 85(5):841-848. PubMed ID: 26620725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of a testosterone stimulation test in the Virginia opossum (Didelphis virginiana) and its use in evaluating deslorelin contraception.
    Johnston SD; Camacho FC; Carrillo L; Guy N; Govea J; Martinez O; Parãs A; Lisle AT; D'Occhio M
    Reprod Fertil Dev; 2008; 20(5):563-9. PubMed ID: 18577353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential responses in anterior pituitary luteinizing hormone (LH) content and LH beta- and alpha-subunit mRNA, and plasma concentrations of LH and testosterone, in bulls treated with the LH-releasing hormone agonist deslorelin.
    Aspden WJ; Rao A; Rose K; Scott PT; Clarke IJ; Trigg TE; Walsh J; D'Occhio MJ
    Domest Anim Endocrinol; 1997 Nov; 14(6):429-37. PubMed ID: 9437579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversibility of germinative and endocrine testicular function after long-term contraception with a GnRH-agonist implant in the tom-a follow-up study.
    Goericke-Pesch S; Georgiev P; Antonov A; Vodenicharov A; Navarro C; Wehrend A
    Theriogenology; 2014 Apr; 81(7):941-6. PubMed ID: 24581586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.